awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42770955-45E065DB-D54A-40A1-8DEA-C691FE198A2B
Q42770955-45E065DB-D54A-40A1-8DEA-C691FE198A2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-45E065DB-D54A-40A1-8DEA-C691FE198A2B
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.
P2860
Q42770955-45E065DB-D54A-40A1-8DEA-C691FE198A2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-45E065DB-D54A-40A1-8DEA-C691FE198A2B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
830bab48ca3b76986406b17640a40b7d40afa6e9
P2860
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.